Long-Term Follow-Up of the Anthracyclines in Early Breast Cancer Trials (USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 [NRG Oncology])

Post time 2024-4-19 13:45:01

journal：Journal of Clinical Oncology

Authors：Charles E. Geyer; Joanne L. Blum; Greg Yothers; Lina Asmar; Patrick J. Flynn; Nicholas J. Robert; Judith O. Hopkins; Joyce A. O'Shaughnessy; Priya Rastogi; Shannon L. Puhalla; Christie J. Hilton; Chau T. Dang; Henry Leonidas Gómez; Svetislava J. Vukelja; Alan P. Lyss; Devchand Paul; Adam M. Brufsky; Linda H. Colangelo; Sandra M. Swain; Eleftherios P. Mamounas; Norman Wolmark

Published date：2024-4-20

DOI：10.1200/jco.23.01428

PDF link：https://ascopubs.org/doi/pdfdirect/10.1200/JCO.23.01428

Article link：http://dx.doi.org/10.1200/jco.23.01428

Article Source：American Society of Clinical Oncology (ASCO)。

Remark：

Post time 2024-4-19 13:45:02

: This post has been completed
Completed attachments will be deleted within 24 hours.

[Other] Long-Term Follow-Up of the Anthracyclines in Early Breast Cancer Trials (USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 [NRG Oncology])

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today

[Other] Long-Term Follow-Up of the Anthracyclines in Early Breast Cancer Trials (USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 [NRG Oncology]) Copy

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today

[Other] Long-Term Follow-Up of the Anthracyclines in Early Breast Cancer Trials (USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 [NRG Oncology])